一个全面的CYP2D6药物-药物-基因相互作用网络,用于精确剂量和药物开发
Simeon Rüdesheim1,2, Helena Leonie Hanae Loer1, Denise Feick1,3
1Clinical Pharmacy, Saarland University, Saarbrücken, Germany.
Clinical pharmacology and therapeutics
|February 15, 2025
概括
基于生理学的药理动力学 (PBPK) 建模网络可以预测复杂的药物-药物-基因相互作用 (DDGIs),帮助临床剂量建议. 这项研究开发了CYP2D6的PBPK网络,证明了其用于精确剂量的潜力.
科学领域:
- 药理学和临床药理学
- 计算生物学和生物信息学
- 药物代谢和药理动力学
背景情况:
- 药物-药物-基因相互作用 (DDGI) 由于其复杂性,对临床剂量建议构成挑战.
- 基于生理学的药理动力学 (PBPK) 建模提供了一种有希望的方法来导航这些复杂的相互作用,并为临床指导方针提供信息.
- 细胞染色体P450 (CYP) 2D6酶是DDGIs的关键参与者,这是由于遗传变异性和药物相互作用.
研究的目的:
- 开发和验证一个全面的PBPK网络,用于建模CYP2D6介导的药物基因相互作用 (DGI),药物相互作用 (DDI) 和DDGI.
- 评估PBPK网络对涉及CYP2D6基质和抑制剂的各种相互作用类型的预测性能.
- 为了证明PBPK网络在未经测试的DDGI场景中对个性化剂量调整的潜在临床实用性.
主要方法:
- 基于FDA指导,构建PBPK网络,包含23种化合物,包括CYP2D6基质和抑制剂 (敏感,中度,强,弱).
- 包括由CYP3A4和P-糖蛋白介导的相互作用以及CYP2D6.
- 开发基于30个DGI,45个DDI和7个DDGI研究的数据,涵盖32种独特的药物组合.
主要成果:
- 在所有相互作用类型中,PBPK网络表现出良好的预测性能,AUC比率 (1.40,1.38,1.56) 和Cmax比率 (1.29,1.43,1.60) 的平均几何平均折叠误差.
- 该模型成功预测了涉及敏感和中度CYP2D6基质和抑制剂的相互作用.
- 该网络用于在模拟的DDGI场景中计算atomoxetine和metoprolol的剂量调整.
结论:
- PBPK建模网络为探索复杂的DDGI提供了强大的框架,特别是对于高度多态的CYP2D6酶.
- 开发的PBPK网络显示出强大的预测准确性,支持其在监管提交和临床实践中的使用.
- 这种方法促进了基于模型的精确剂量定量,使得对具有挑战性的DDGI场景进行患者特定的剂量调整.
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
71
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
71
Analysis of Population Pharmacokinetic Data
216
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
216
Nonlinear Pharmacokinetics: Overview
250
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
250
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
26
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
26
Drug Concentration Versus Time Correlation
577
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
577
Nonlinear Pharmacokinetics: Role of Transporters
27
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
27


